RSS-Feed abonnieren

DOI: 10.1055/a-1970-9590
Ein Update zur Leishmaniose des Hundes: Diagnostik, Therapie und Monitoring
Canine leishmaniosis: an update regarding diagnostics, therapeutic approaches, and monitoring

Zusammenfassung
Aufgrund von steigenden Importzahlen von Hunden aus dem Ausland, zunehmendem Reiseverkehr sowie den Veränderungen klimatischer Bedingungen in Europa gewinnen Infektionen mit Leishmania (L.) infantum bei Hunden in Deutschland zunehmend an Bedeutung. Daher sollten auch Hunde aus dem Ausland, die keine klinischen Symptome zeigen, direkt nach Import sowie erneut 6 Monate später auf vektorübertragene Infektionserreger getestet werden. Bei Hunden mit klinischer Symptomatik, die hinweisend auf eine Leishmaniose sind, werden direkte und indirekte Nachweisverfahren sowie eine hämatologische und biochemische Untersuchung unter Einbezug von Serumeiweißelektrophorese sowie Bestimmung des C-reaktiven Proteins empfohlen. Als Leitfaden für die Therapie sowie das Monitoring stehen die LeishVet-Guidelines zur Verfügung. Es stehen leishmanizide und leishmaniostatische Wirkstoffe zur Verfügung, die in first-line, second-line und third-line unterschieden werden. Zur Anpassung der Allopurinol-Dosierung wird der Stufenplan empfohlen. Aufgrund der Veränderung der klimatischen Bedingungen kommt es zu einer Ausbreitung der Habitate von Sandmücken, die als Vektoren der Leishmaniose bekannt sind. Als weitere Infektionsquellen sind Deckakte, transplazentare Infektionen, Bisswunden und Bluttransfusionen beschrieben. Leishmania infantum hat zoonotisches Potential und ist daher auch in Hinblick auf den „One-Health“-Gedanken bedeutend.
Abstract
Canine infections with Leishmania (L.) infantum are gaining significance in Germany due to rising numbers of dogs imported from endemic countries, frequent travel and changing of climatic conditions in Central Europe. Dogs without any clinical signs suspicious for vector-borne infections imported from other countries to Germany should be tested immediately after import and 6 months later. In dogs with clinical signs suspicious for leishmaniosis, direct and indirect detection methods of the pathogen as well as hematology, biochemistry, serum protein electrophoresis and C-reactive protein are recommended. For treatment and monitoring of canine leishmaniosis, the LeishVet-guidelines are highly recommended. Different therapeutic options include first-line, second-line, and third-line drugs. For dose adjustments of allopurinol, the “step plan” should be taken in consideration. Due to climatic changes, habitats of sandflies as transmitting vectors of leishmaniosis are expanding. Next to vectorial transmission mating, transplacental infections, bite wounds, and blood transfusions were described in canine leishmaniosis. Additionally, L. infantum is a zoonotic vector-borne infectious pathogen, which is important regarding the “One-health”-aspect.
Publikationsverlauf
Eingereicht: 09. Februar 2022
Angenommen: 31. Oktober 2022
Artikel online veröffentlicht:
14. Dezember 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Lane RP. Sandflies (Phlebotominae). In: Lane DRP, Crosskey DRW. eds. Medical insects and arachnids. Dordrecht, Netherlands: Springer; 1993: 78-119
- 2 Young DG, Perkins PV. Phlebotomine Sand Flies of North-America (Diptera, Psychodidae). Mosq News 1984; 44 (02) 263-304
- 3 Lewis DJ. A taxonomic review of the genus Phlebotomus (Diptera: Psychodidae). Bull Br Mus Nat Hist Entomol 1982; 45 (02) 121-209
- 4 Volf P, Hostomska J, Rohousova I. Molecular crosstalks in Leishmania-sandfly-host relationships. Parasite 2008; 15 (03) 237-243
- 5 Killick-Kendrick R. editor Biology of sand fly vectors of Mediterranean canine leishmaniasis. International Canine Leishmaniasis Forum. 1999 Barcelona, Spain
- 6 Dantas-Torres F. The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis. Vet Parasitol 2007; 149 (03/04) 139-146
- 7 Gramiccia M, Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int J Parasitol 2005; 35 (11/12) 1169-1180
- 8 Baneth G, Koutinas AF, Solano-Gallego L. et al. Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one. Trends Parasitol 2008; 24 (07) 324-330
- 9 Solano-Gallego L, Koutinas A, Miro G. et al. Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. Vet Parasitol 2009; 165 (01/02) 1-18
- 10 Owens SD, Oakley DA, Marryott K. et al. Transmission of visceral leishmaniasis through blood transfusions from infected English foxhounds to anemic dogs. J Am Vet Med Assoc 2001; 219 (08) 1076-1083
- 11 de Freitas E, Melo MN, da Costa-Val AP. et al. Transmission of Leishmania infantum via blood transfusion in dogs: potential for infection and importance of clinical factors. Vet Parasitol 2006; 137 (01/02) 159-167
- 12 Tabar MD, Roura X, Francino O. et al. Detection of Leishmania infantum by real-time PCR in a canine blood bank. J Small Anim Pract 2008; 49 (07) 325-328
- 13 Silva FL, Oliveira RG, Silva TM. et al. Venereal transmission of canine visceral leishmaniasis. Vet Parasitol 2009; 160 (01/02) 55-59
- 14 Rosypal AC, Troy GC, Zajac AM. et al. Transplacental transmission of a North American isolate of Leishmania infantum in an experimentally infected beagle. J Parasitol 2005; 91 (04) 970-972
- 15 Pangrazio KK, Costa EA, Amarilla SP. et al. Tissue distribution of Leishmania chagasi and lesions in transplacentally infected fetuses from symptomatic and asymptomatic naturally infected bitches. Vet Parasitol 2009; 165 (03/04) 327-331
- 16 Boggiatto PM, Gibson-Corley KN, Metz K. et al. Transplacental transmission of Leishmania infantum as a means for continued disease incidence in North America. PLoS Negl Trop Dis 2011; 5 (04) e1019
- 17 Shaw SE, Langton DA, Hillman TJ. Canine leishmaniosis in the United Kingdom: a zoonotic disease waiting for a vector?. Vet Parasitol 2009; 163 (04) 281-285
- 18 Naucke TJ, Amelung S, Lorentz S. First report of transmission of canine leishmaniosis through bite wounds from a naturally infected dog in Germany. Parasite Vector 2016; 9
- 19 Coutinho MT, Bueno LL, Sterzik A. et al. Participation of Rhipicephalus sanguineus (Acari: Ixodidae) in the epidemiology of canine visceral leishmaniasis. Vet Parasitol 2005; 128 (01/02) 149-155
- 20 Dantas-Torres F. Biology and ecology of the brown dog tick, Rhipicephalus sanguineus. Parasit Vectors 2010; 3: 26
- 21 Paz GF, Ribeiro MF, de Magalhaes DF. et al. Association between the prevalence of infestation by Rhipicephalus sanguineus and Ctenocephalides felis felis and the presence of anti-Leishmania antibodies: A case-control study in dogs from a Brazilian endemic area. Prev Vet Med 2010; 97 (02) 131-133
- 22 Dantas-Torres F. Ticks as vectors of Leishmania parasites. Trends Parasitol 2011; 27 (04) 155-159
- 23 Dantas-Torres F, Latrofa MS, Otranto D. Quantification of Leishmania infantum DNA in females, eggs and larvae of Rhipicephalus sanguineus. Parasit Vectors 2011; 4: 56
- 24 Coutinho MTZ, Linardi PM. Can fleas from dogs infected with canine visceral leishmaniasis transfer the infection to other mammals?. Vet Parasitol 2007; 147 (03/04) 320-325
- 25 Röhrig E, Hamel D, Pfister K. Retrospective evaluation of laboratory data on canine vector-borne infections from the years 2004–2008. Berl Munch Tierarztl Wochenschr 2011; 124 (09/10) 411-418 (In German)
- 26 Schäfer I, Volkmann M, Beelitz P. et al. Retrospective evaluation of vector-borne infections in dogs imported from the Mediterranean region and southeastern Europe (2007–2015). Parasit Vectors 2019; a; 12 (01) 30
- 27 Menn B, Lorentz S, Naucke TJ. Imported and travelling dogs as carriers of canine vector-borne pathogens in Germany. Parasit Vectors 2010; 3: 34
- 28 Hamel D, Röhrig E, Pfister K. Canine vector-borne disease in travelled dogs in Germany--a retrospective evaluation of laboratory data from the years 2004–2008. Vet Parasitol 2011; 181 (01) 31-36
- 29 Schäfer I, Volkmann M, Beelitz P. et al. Retrospective analysis of vector-borne infections in dogs after travelling to endemic areas (2007–2018). Vet Parasitol X 2: 100015 2019; b.
- 30 Hamel D, Silaghi C, Pfister K. Arthropod-borne infections in travelled dogs in Europe. Parasite 2013; 20: 9 10.1051/parasite/2013010
- 31 Gothe R. Leishmaniosen des Hundes in Deutschland: Erregerfauna und -biologie, Epidemiologie, Klinik, Pathogenese, Diagnose, Therapie und Prophylaxe. Kleintierpraxis 1991; 36: 69-84
- 32 Naucke TJ, Schmitt C. Is leishmaniasis becoming endemic in Germany?. Int J Med Microbiol 2004; 293 (Suppl. 37) 179-181
- 33 Naucke TJ, Pesson B. Presence of Phlebotomus (Transphlebotomus) mascittii Grassi, 1908 (Diptera : Psychodidae) in Germany. Parasitol Res 2000; 86 (04) 335-336
- 34 Naucke TJ, Menn B, Massberg D. et al. Sandflies and leishmaniasis in Germany. Parasitol Res 2008; 103 (Suppl. 01) S65-68 10.1007/s00436-008-1052-y
- 35 Melaun C, Kruger A, Werblow A. et al. New record of the suspected leishmaniasis vector Phlebotomus (Transphlebotomus) mascittii Grassi, 1908 (Diptera: Psychodidae: Phlebotominae)--the northernmost phlebotomine sandfly occurrence in the Palearctic region. Parasitol Res 2014; 113 (06) 2295-2301
- 36 Obwaller AG, Karakus M, Poeppl W. et al. Could Phlebotomus mascittii play a role as a natural vector for Leishmania infantum? New data. Parasit Vectors 2016; 9: 458
- 37 Fischer D, Thomas SM, Beierkuhnlein C. Temperature-derived potential for the establishment of phlebotomine sandflies and visceral leishmaniasis in Germany. Geospat Health 2010; 5 (01) 59-69
- 38 Solano-Gallego L, Miro G, Koutinas A. et al. LeishVet guidelines for the practical management of canine leishmaniosis. Parasit Vectors 2011; 4: 86
- 39 Baneth G, Aroch I. Canine leishmaniasis: a diagnostic and clinical challenge. Vet J 2008; 175 (01) 14-15
- 40 Baneth G, Solano-Gallego L. Leishmaniasis. In: Greene CE. editor. Infectious Diseases of the Dog and Cat. 4th edn.. Oxford: Elsevier; 2012: 734-749
- 41 Gharbi M, Mhadhbi M, Rejeb A. et al. Leishmaniosis (Leishmania infantum infection) in dogs. Rev Sci Tech 2015; 34 (02) 613-626
- 42 Ciaramella P, Oliva G, Luna RD. et al. A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet Rec 1997; 141 (21) 539-543
- 43 Blavier A, Keroack S, Denerolle P. et al. Atypical forms of canine leishmaniosis. Vet J 2001; 162 (02) 108-120
- 44 Iniesta L, Fernandez-Barredo S, Bulle B. et al. Diagnostic techniques to detect cryptic leishmaniasis in dogs. Clin Diagn Lab Immunol 2002; 9 (05) 1137-1141
- 45 Chulay JD, Bryceson AD. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg 1983; 32 (03) 475-479
- 46 Paltrinieri S, Solano-Gallego L, Fondati A. et al. Guidelines for diagnosis and clinical classification of leishmaniasis in dogs. J Am Vet Med Assoc 2010; 236 (11) 1184-1191
- 47 Paltrinieri S, Gradoni L, Roura X. et al. Laboratory tests for diagnosing and monitoring canine leishmaniasis. Vet Clin Pathol 2016; 45 (04) 552-578
- 48 Ferreira Sde A, Ituassu LT, de Melo MN. et al. Evaluation of the conjunctival swab for canine visceral leishmaniasis diagnosis by PCR-hybridization in Minas Gerais State, Brazil. Vet Parasitol 2008; 152 (03/04) 257-263
- 49 Gramiccia M, Di Muccio T, Fiorentino E. et al. Longitudinal study on the detection of canine Leishmania infections by conjunctival swab analysis and correlation with entomological parameters. Vet Parasitol 2010; 171 (03/04) 223-228
- 50 EFSA Panel on Animal Health and Welfare. Scientific opinion on canine leishmaniosis. EFSA Journal 2015; 13: 4075
- 51 Cortes S, Rolao N, Ramada J. et al. PCR as a rapid and sensitive tool in the diagnosis of human and canine leishmaniasis using Leishmania donovani s. l. specific kinetoplastid primers. Trans R Soc Trop Med Hyg 2004; 98: 12-17
- 52 Francino O, Altet L, Sanchez-Robert E. et al. Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Vet Parasitol 2006; 137 (03/04) 214-221
- 53 Martinez V, Quilez J, Sanchez A. et al. Canine leishmaniasis: the key points for qPCR result interpretation. Parasit Vectors 2011; 4: 57
- 54 Andrade HM, de Toledo VDCP, Marques MJ. et al. Leishmania (Leishmania) chagasi is not vertically transmitted in dogs. Vet Parasitol 2002; 103 (01/02) 71-81
- 55 Ramos RA, Ramos CA, Santos EM. et al. Quantification of Leishmania infantum DNA in the bone marrow, lymph node and spleen of dogs. Rev Bras Parasitol Vet 2013; 22 (03) 346-350
- 56 Carvalho Ferreira AL, Carregal VM, de Almeida Ferreira S. et al. Detection of Leishmania infantum in 4 different dog samples by real-time PCR and ITS-1 nested PCR. Diagn Microbiol Infect Dis 2014; 78 (04) 418-421
- 57 Almeida AB, Sousa VR, Gasparetto ND. et al. Canine visceral leishmaniasis: diagnostic approaches based on polymerase chain reaction employing different biological samples. Diagn Microbiol Infect Dis 2013; 76 (03) 321-324
- 58 Reis LE, Coura-Vital W, Roatt BM. et al. Molecular diagnosis of canine visceral leishmaniasis: a comparative study of three methods using skin and spleen from dogs with natural Leishmania infantum infection. Vet Parasitol 2013; 197 (03/04) 498-503
- 59 Di Muccio T, Veronesi F, Antognoni MT. et al. Diagnostic value of conjunctival swab sampling associated with nested PCR for different categories of dogs naturally exposed to Leishmania infantum infection. J Clin Microbiol 2012; 50 (08) 2651-2659
- 60 Ferreira Sde A, Almeida GG, Silva Sde O. et al. Nasal, oral and ear swabs for canine visceral leishmaniasis diagnosis: new practical approaches for detection of Leishmania infantum DNA. PLoS Negl Trop Dis 2013; 7 (04) e2150
- 61 Saridomichelakis MN, Mylonakis ME, Leontides LS. et al. Evaluation of lymph node and bone marrow cytology in the diagnosis of canine leishmaniasis (Leishmania infantum) in symptomatic and asymptomatic dogs. Am J Trop Med Hyg 2005; 73 (01) 82-86
- 62 Moreira MA, Luvizotto MC, Garcia JF. et al. Comparison of parasitological, immunological and molecular methods for the diagnosis of leishmaniasis in dogs with different clinical signs. Vet Parasitol 2007; 145 (03/04) 245-252
- 63 Giudice E, Passantino A. Detection of Leishmania amastigotes in peripheral blood from four dogs--Short communication. Acta Vet Hung 2011; 59 (02) 205-213
- 64 Ruiz De Gopegui R, Espada Y. Peripheral blood and abdominal fluid from a dog with abdominal distention. Vet Clin Pathol 1998; 27 (02) 64
- 65 Moreno J, Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol 2002; 18 (09) 399-405
- 66 Quinnell RJ, Courtenay O, Garcez LM. et al. IgG subclass responses in a longitudinal study of canine visceral leishmaniasis. Vet Immunol Immunopathol 2003; 91 (03/04) 161-168
- 67 Solano-Gallego L, Llull J, Ramis A. et al. Longitudinal study of dogs living in an area of Spain highly endemic for leishmaniasis by serologic analysis and the leishmanin skin test. Am J Trop Med Hyg 2005; 72 (06) 815-818
- 68 Mettler M, Grimm F, Capelli G. et al. Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs. J Clin Microbiol 2005; 43 (11) 5515-5519
- 69 Ferreira Ede C, de Lana M, Carneiro M. et al. Comparison of serological assays for the diagnosis of canine visceral leishmaniasis in animals presenting different clinical manifestations. Vet Parasitol 2007; 146 (03/04) 235-241
- 70 Maia C, Campino L. Methods for diagnosis of canine leishmaniasis and immune response to infection. Vet Parasitol 2008; 158 (04) 274-287
- 71 Grimaldi Jr. G, Teva A, Ferreira AL. et al. Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP(R) CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis. Trans R Soc Trop Med Hyg 2012; 106 (01) 54-59
- 72 Villanueva-Saz S, Martínez M, Ramirez JD. et al. Evaluation of five different rapid immunochromatographic tests for canine leishmaniosis in Spain. Acta Trop 2022; 229: 106371
- 73 Sousa S, Cardoso L, Reed SG. et al. Development of a fluorescent based immunosensor for the serodiagnosis of canine leishmaniasis combining immunomagnetic separation and flow cytometry. PLoS Negl Trop Dis 2013; 7 (08) e2371
- 74 Ker HG, Coura-Vital W, Aguiar-Soares RD. et al. Evaluation of a prototype flow cytometry test for serodiagnosis of canine visceral leishmaniasis. Clin Vaccine Immunol 2013; 20 (12) 1792-1798
- 75 Ramos-Jesus J, Carvalho KA, Fonseca RA. et al. A piezoelectric immunosensor for Leishmania chagasi antibodies in canine serum. Anal Bioanal Chem 2011; 401 (03) 917-925
- 76 Akhoundi B, Mohebali M, Shojaee S. et al. Rapid detection of human and canine visceral leishmaniasis: assessment of a latex agglutination test based on the A2 antigen from amastigote forms of Leishmania infantum. Exp Parasitol 2013; 133 (03) 307-313
- 77 Facchini RV, Bertazzolo W, Zuliani D. et al. Detection of biclonal gammopathy by capillary zone electrophoresis in a cat and a dog with plasma cell neoplasia. Vet Clin Pathol 2010; 39 (04) 440-446
- 78 Antognoni MT, Birettoni F, Miglio A. et al. Monoclonal gammopathy associated with multiple myeloma and visceral leishmaniasis in the dog: a comparison of two cases. Vet Res Commun 2010; 34 (Suppl. 01) S97-101
- 79 Giordano A, Paltrinieri S. Interpretation of capillary zone electrophoresis compared with cellulose acetate and agarose gel electrophoresis: reference intervals and diagnostic efficiency in dogs and cats. Vet Clin Pathol 2010; 39 (04) 464-473
- 80 ESCCAP. Control of Vector-Borne Diseases in Dogs and Cats. Series Eds. editor^editors: European Scientific Counsel Companion Animal Parasites. 2019
- 81 Martinez-Subiela S, Strauss-Ayali D, Ceron JJ. et al. Acute phase protein response in experimental canine leishmaniasis. Vet Parasitol 2011; 180 (03/04) 197-202
- 82 Daza Gonzalez MA, Fragio Arnold C, Fermin Rodriguez M. et al. Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis. Vet J 2019; 245: 22-28
- 83 Pardo-Marin L, Ceron JJ, Tecles F. et al. Comparison of acute phase proteins in different clinical classification systems for canine leishmaniosis. Vet Immunol Immunopathol 2020; 219: 109958
- 84 Cantos-Barreda A, Escribano D, Ceron JJ. et al. Relationship between serum anti-Leishmania antibody levels and acute phase proteins in dogs with canine leishmaniosis. Vet Parasitol 2018; 260: 63-68
- 85 Denerolle P, Bourdoiseau G. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J Vet Intern Med 1999; 13 (05) 413-415
- 86 Noli C, Auxilia ST. Treatment of canine Old World visceral leishmaniasis: a systematic review. Vet Dermatol 2005; 16 (04) 213-232
- 87 Manna L, Reale S, Vitale F. et al. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. Vet J 2008; 177 (02) 279-282
- 88 Miro G, Oliva G, Cruz I. et al. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Vet Dermatol 2009; 20 (05/06) 397-404
- 89 Mary C, Faraut F, Deniau M. et al. Frequency of drug resistance gene amplification in clinical leishmania strains. Int J Microbiol 2010; 2010
- 90 Sundar S, Singh A, Rai M. et al. Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 study. Am J Trop Med Hyg 2015; 92 (03) 513-517
- 91 Monge-Maillo B, Lopez-Velez R. Therapeutic options for visceral leishmaniasis. Drugs 2013; 73 (17) 1863-1888
- 92 Poli A, Sozzi S, Guidi G. et al. Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis. Vet Parasitol 1997; 71 (04) 263-271
- 93 Oliva G, Gradoni L, Cortese L. et al. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis. Ann Trop Med Parasitol 1998; 92 (02) 165-171
- 94 Rhalem A, Sahibi H, Lasri S. et al. Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment. Vet Immunol Immunopathol 1999; 71: 69-76
- 95 Pennisi MG, De Majo M, Masucci M. et al. Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin. Vet Rec 2005; 156 (11) 346-349
- 96 Segarra S, Miro G, Montoya A. et al. Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound. Parasit Vectors 2018; 11 (01) 103
- 97 Segarra S, Miro G, Montoya A. et al. Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis. Vet Parasitol 2017; 239: 50-56
- 98 Travi BL, Miro G. Use of domperidone in canine visceral leishmaniasis: gaps in veterinary knowledge and epidemiological implications. Mem Inst Oswaldo Cruz 2018; 113 (11) e180301
- 99 Cavalera MA, Gernone F, Uva A. et al. Effect of domperidone (leisguard(R)) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease. Parasit Vectors 2021; 14 (01) 525
- 100 Orav A, Raal A, Arak E. Content and composition of the essential oil of Chamomilla recutita (L.) Rauschert from some European countries. Nat Prod Res 2010; 24 (01) 48-55
- 101 Forrer M, Kulik EM, Filippi A. et al. The antimicrobial activity of alpha-bisabolol and tea tree oil against Solobacterium moorei, a Gram-positive bacterium associated with halitosis. Arch Oral Biol 2013; 58 (01) 10-16
- 102 Maurya AK, Singh M, Dubey V. et al. alpha-(-)-bisabolol reduces pro-inflammatory cytokine production and ameliorates skin inflammation. Curr Pharm Biotechnol 2014; 15 (02) 173-181
- 103 Bhatia SP, McGinty D, Letizia CS. et al. Fragrance material review on alpha-bisabolol. Food Chem Toxicol 2008; 46 (Suppl. 11) S72-76
- 104 Corpas-Lopez V, Merino-Espinosa G, Lopez-Viota M. et al. Topical treatment of Leishmania tropica infection using (-)-alpha-Bisabolol ointment in a hamster model: effectiveness and safety assessment. J Nat Prod 2016; 79 (09) 2403-2407
- 105 Corpas-Lopez V, Morillas-Marquez F, Navarro-Moll MC. et al. (-)-alpha-Bisabolol, a promising oral compound for the treatment of visceral leishmaniasis. J Nat Prod 2015; 78 (06) 1202-1207
- 106 Corpas-Lopez V, Merino-Espinosa G, Acedo-Sanchez C. et al. Effectiveness of the sesquiterpene (-)-alpha-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial. Vet Res Commun 2018; 42 (02) 121-130
- 107 Shakir L, Hussain M, Javeed A. et al. Artemisinins and immune system. European Journal of Pharmacology 2011; 668 (01/02) 6-14
- 108 Tejada R. Artemisia annua contra la leishmaniosis canina: cuatro casos clinicos. Revista de Fitoterapia 2016; 16: 123-129
- 109 Zaidi A, Singh KP, Ali V. Leishmania and its quest for iron: An update and overview. Mol Biochem Parasitol 2017; 211: 15-25
- 110 Niu Q, Li S, Chen D. et al. Iron acquisition in Leishmania and its crucial role in infection. Parasitol 2016; 143 (11) 1347-1357
- 111 LupoVet GmbH – veterinary diets. Im Internt: Zugriff am 04. Januar 2022 unter: https://www.lupovet.de/produkte/ergaenzer-fuer-hunde/lupovet-ergaenzer-a-z/42/luparte-2.0
- 112 Helm M, Müller W, Schaarschmidt-Kiener D. et al. Allopurinol-Therapie bei importierten Hunden mit Leishmaniose außerhalb des Endemiegebietes. Schweiz Arch Tierheilkd 2013; 155: 559-567
- 113 Yasur-Landau D, Jaffe CL, David L. et al. Allopurinol resistance in Leishmania infantum from dogs with disease relapse. PLoS Negl Trop Dis 2016; 10 (01) e0004341
- 114 Yasur-Landau D, Jaffe CL, David L. et al. Resistance of Leishmania infantum to allopurinol is associated with chromosome and gene copy number variations including decrease in the S-adenosylmethionine synthetase (METK) gene copy number. Int J Parasitol-Drug 2018; 8 (03) 403-410
- 115 Yasur-Landau D, Jaffe CL, Doron-Faigenboim A. et al. Induction of allopurinol resistance in Leishmania infantum isolated from dogs. PLoS Negl Trop Dis 2017; 11 (09) e0005910
- 116 Geisweid K, Mueller R, Sauter-Louis C. et al. Prognostic analytes in dogs with Leishmania infantum infection living in a non-endemic area. Vet Rec 2012; 171 (16) 399
- 117 Jacob F, Polzin DJ, Osborne CA. et al. Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure. J Am Vet Med Assoc 2005; 226 (03) 393-400
- 118 International renal Interest Society (IRIS). Guidelines for Staging Chronic Kidney Disease (CKD). Im Internet: Zugriff am 24. Dezember 2021 unter: www.iris-kidney.com
- 119 Roura X, Fondati A, Lubas G. et al. Prognosis and monitoring of leishmaniasis in dogs: a working group report. Vet J 2013; 198 (01) 43-47
- 120 Group IGDS, Goldstein RE, Brovida C. et al. Consensus recommendations for treatment for dogs with serology positive glomerular disease. J Vet Intern Med 2013; 27 (Suppl. 01) S60-66
- 121 Rossi G, Ibba F, Meazzi S. et al. Paraoxonase activity as a tool for clinical monitoring of dogs treated for canine leishmaniasis. Vet J 2014; 199 (01) 143-149
- 122 Torres M, Bardagi M, Roura X. et al. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. Vet J 2011; 188 (03) 346-351
- 123 Rougier S, Hasseine L, Delaunay P. et al. One-year clinical and parasitological follow-up of dogs treated with marbofloxacin for canine leishmaniosis. Vet Parasitol 2012; 186 (03/04) 245-253
- 124 Manna L, Corso R, Galiero G. et al. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol. Parasit Vectors 2015; 8: 289
- 125 Solano-Gallego L, Di Filippo L, Ordeix L. et al. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease. Parasit Vectors 2016; 9 (01) 235
- 126 Martinez-Subiela S, Bernal LJ, Ceron JJ. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment. Am J Vet Res 2003; 64 (08) 1021-1026
- 127 Sasanelli M, Paradies P, de Caprariis D. et al. Acute-phase proteins in dogs naturally infected with Leishmania infantum during and after long-term therapy with allopurinol. Vet Res Commun 2007; 31 (Suppl. 01) 335-338
- 128 Aresu L, Benali S, Ferro S. et al. Light and electron microscopic analysis of consecutive renal biopsy specimens from Leishmania-seropositive dogs. Vet Pathol 2013; 50 (05) 753-760
- 129 Bianciardi P, Brovida C, Valente M. et al. Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys. Toxicol Pathol 2009; 37 (06) 770-775
- 130 Xenoulis PG, Saridomichelakis MN, Chatzis MK. et al. Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate. Vet Parasitol 2014; 203 (03/04) 326-330
- 131 Luciani A, Sconza S, Civitella C. et al. Evaluation of the cardiac toxicity of N-methyl-glucamine antimoniate in dogs with naturally occurring leishmaniasis. Vet J 2013; 196 (01) 119-121
- 132 Aste G, Di Tommaso M, Steiner JM. et al. Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis. Vet Res Commun 2005; 29 (Suppl. 02) 269-272
- 133 Torres M, Pastor J, Roura X. et al. Adverse urinary effects of allopurinol in dogs with leishmaniasis. J Small Anim Pract 2016; 57 (06) 299-304
- 134 Osborne CA, Lulich JP, Swanson LL. et al. Drug-induced urolithiasis. Vet Clin North Am Small Anim Pract 2009; 39 (01) 55-63
- 135 Roura X, Cortadellas O, Day MJ. et al. Canine leishmaniosis and kidney disease: Q & A for an overall management in clinical practice. J Small Anim Pract 2021; 62 (01) E1-E19
- 136 Dantas-Torres F, Miro G, Baneth G. et al. Canine leishmaniasis control in the context of one health. Emerg Infect Dis. 2019 25. 12
- 137 Miro G, Galvez R, Mateo M. et al. Evaluation of the efficacy of a topically administered combination of imidacloprid and permethrin against Phlebotomus perniciosus in dog. Vet Parasitol 2007; 143 (03/04) 375-379
- 138 Mencke N, Volf P, Volfova V. et al. Repellent efficacy of a combination containing imidacloprid and permethrin against sand flies (Phlebotomus papatasi) in dogs. Parasitol Res 2003; 90 (Suppl. 03) S108-111
- 139 Killick-Kendrick R, Killick-Kendrick M, Focheux C. et al. Protection of dogs from bites of phlebotomine sandflies by deltamethrin collars for control of canine leishmaniasis. Med Vet Entomol 1997; 11 (02) 105-111
- 140 Otranto D, Paradies P, Lia RP. et al. Efficacy of a combination of 10 % imidacloprid/50 % permethrin for the prevention of leishmaniasis in kennelled dogs in an endemic area. Vet Parasitol 2007; 144 (03/04) 270-278
- 141 Maroli M, Mizzoni V, Siragusa C. et al. Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin-impregnated dog collars in southern Italy. Med Vet Entomol 2001; 15 (04) 358-363
- 142 Foglia Manzillo V, Oliva G, Pagano A. et al. Deltamethrin-impregnated collars for the control of canine leishmaniasis: evaluation of the protective effect and influence on the clinical outcome of Leishmania infection in kennelled stray dogs. Vet Parasitol 2006; 142 (01/02) 142-145
- 143 Otranto D, de Caprariis D, Lia RP. et al. Prevention of endemic canine vector-borne diseases using imidacloprid 10 % and permethrin 50 % in young dogs: a longitudinal field study. Vet Parasitol 2010; 172 (03/04) 323-332
- 144 Gavgani AS, Hodjati MH, Mohite H. et al. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 2002; 360 (9330) 374-379
- 145 Alexander B, Maroli M. Control of phlebotomine sandflies. Med Vet Entomol 2003; 17 (01) 1-18
- 146 Maroli M, Gradoni L, Oliva G. et al. Guidelines for prevention of leishmaniasis in dogs. J Am Vet Med Assoc 2010; 236 (11) 1200-1206
- 147 Velez R, Gallego M. Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy. Trop Med Int Health 2020; 25 (05) 540-557
- 148 Lemesre JL, Holzmuller P, Goncalves RB. et al. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Vaccine 2007; 25 (21) 4223-4234
- 149 Cacheiro-Llaguno C, Parody N, Renshaw-Calderon A. et al. Vaccination with LetiFend(R) reduces circulating immune complexes in dogs experimentally infected with L. infantum. Vaccine 2020; 38 (04) 890-896
- 150 Molano I, Alonso MG, Miron C. et al. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. Vet Immunol Immunopathol 2003; 92 (01/02) 1-13
- 151 Iniesta V, Fernández-Cotrina J, Solano-Gallego L. et al., editors Vaccination with LetiFend®, a novel canine leishmaniosis vaccine, does not interfere with serological diagnostic tests. X Southern European Veterinary Conference/51º Congreso Nacional Avepa; 2016 20–22 October 2016; Granada (Spain).
- 152 Saraiva EM, de Figueiredo Barbosa A, Santos FN. et al. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine. Vaccine 2006; 24 (13) 2423-2431
- 153 Fernandes AP, Costa MM, Coelho EA. et al. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine 2008; 26 (46) 5888-5895